This is same CEO he repeated that 3 trials will start before 2017 - people were blaming FDA but he had not even started submission of protocol for 2 - AD protocol may not be submitted for 3 months and PD trial was being planned to move out of country and Rett 1st response must be on hand as he resubmitted the IND in 2018.
Despite this clear information on hand - he gave incorrect information. So at least I will take his word with pinch or bucket of salt.
I will wait for official PRs telling me that a. When Rett IND is approved and when trial is actually starting b. Protocol for PD gets approved and site gets ready c. Some PR on genomic signature and more details on AD start timeline
Till that time - all the information is informal and he can deny it
It’s called 2 years of salary at 500k per plus whatever shekels he begs for at investors meetings. Another 2 years on his resume. The fact that he has never acknowledged all his missed promises is infuriating. Muhammad Ali is all of his greatness suffered from dementia but worse nearly penniless. There were swarms of parasites who had no more ambition than to take whatever they could extract.
All that said, nice bounce yesterday. Hopefully $2.00 is the floor
Yes, you must take biotech management words appropriately. They are not "The Truth." They are a (naturally) optimistic opinion. This goes for their evaluation of results. The opinions that matter are professional analysts, potential BP partners, and the FDA.
Market Data 
Markets 
AI
